Tokio Marine Holdings, Inc.:企業の戦略・SWOT・財務情報

◆英語タイトル:Tokio Marine Holdings, Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C6254
◆発行会社(調査会社):MarketLine
◆発行日:2018年10月
◆ページ数:59
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Tokio Marine Holdings, Inc. – Strategy, SWOT and Corporate Finance Report
Summary

Tokio Marine Holdings, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Tokio Marine Holdings, Inc. (Tokio Marine) is an insurance holding company. The group, through its subsidiaries, offers a range of life and non-life insurance products and services to individuals and corporate customers. Its portfolio of products includes whole-life insurance, cancer insurance, annuity insurance, auto insurance, travel and personal accident insurance, medical insurance, property insurance, casualty insurance and short-term insurance. The group also provides various services such as asset management, investment trust management and real estate management services. It has operations in the Americas, Europe, Africa, the Middle East, and Asia and Oceania regions. Tokio Marine is headquartered in Tokyo, Japan.In FY2017, the company reported net premiums written of JPY3,564,747 million, which indicates an increase of 2.4% over FY2016.

Scope

- Detailed information on Tokio Marine Holdings, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Tokio Marine Holdings, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Tokio Marine Holdings, Inc. including a breakdown and examination of key business segments
- Intelligence on Tokio Marine Holdings, Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Tokio Marine Holdings, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Tokio Marine Holdings, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Tokio Marine Holdings, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Tokio Marine Holdings, Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Tokio Marine Holdings, Inc.: Company Overview 9
Tokio Marine Holdings, Inc.: Overview and Key Facts 9
Tokio Marine Holdings, Inc.: Overview 9
Tokio Marine Holdings, Inc.: Key Facts 9
Tokio Marine Holdings, Inc.: Key Employees 11
Tokio Marine Holdings, Inc.: Key Employee Biographies 14
Tokio Marine Holdings, Inc.: Major Products and Services 21
Tokio Marine Holdings, Inc.: Company History 22
Tokio Marine Holdings, Inc.: Management Statement 26
Tokio Marine Holdings, Inc.: Locations and Subsidiaries 32
Tokio Marine Holdings, Inc.: Key Competitors 35
Tokio Marine Holdings, Inc.: Company Analysis 36
Tokio Marine Holdings, Inc.: Business Description 36
Tokio Marine Holdings, Inc.: SWOT Analysis 37
Tokio Marine Holdings, Inc.: SWOT Overview 37
Tokio Marine Holdings, Inc.: Strengths 37
Tokio Marine Holdings, Inc.: Weaknesses 38
Tokio Marine Holdings, Inc.: Opportunities 38
Tokio Marine Holdings, Inc.: Threats 39
Tokio Marine Holdings, Inc.: Corporate Financial Deals Activity 41
Tokio Marine Holdings, Inc.: Financial Deals Overview 41
Tokio Marine Holdings, Inc.: Targets and Partners 43
Tokio Marine Holdings, Inc.: Top Deals 2014 – 2018YTD* 44
Tokio Marine Holdings, Inc.: Advisors 45
Tokio Marine Holdings, Inc.: Top Legal Advisors 45
Tokio Marine Holdings, Inc.: Mergers and Acquisitions 46
Tokio Marine Holdings, Inc.: Corporate Venturing 47
Tokio Marine Holdings, Inc.: Partnership 48
Tokio Marine Holdings, Inc.: Recent Developments 49
Tokio Marine Holdings, Inc.: News and Events Summary 49
Tokio Marine Holdings, Inc.: Business Expansion 52
Tokio Marine Holdings, Inc.: Contracts 53
Tokio Marine Holdings, Inc.: Corporate Governance 53
Tokio Marine Holdings, Inc.: Financial Deals 53
Tokio Marine Holdings, Inc.: Financial Performance 54
Tokio Marine Holdings, Inc.: Regulatory and Legal Events 55
Tokio Marine Holdings, Inc.: Strategy and Operations 55
Appendix 57
Contact Us 57
Methodology 57
About MarketLine 58

List of Tables
Table 1: Tokio Marine Holdings, Inc.: Key Facts
Table 2: Tokio Marine Holdings, Inc.: Key Employees
Table 3: Tokio Marine Holdings, Inc.: Company History
Table 4: Tokio Marine Holdings, Inc.: Locations and Subsidiaries
Table 5: Tokio Marine Holdings, Inc.: Key Competitors
Table 6: Tokio Marine Holdings, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Tokio Marine Holdings, Inc.: M&A Activity by Geography (TTM*)
Table 8: Tokio Marine Holdings, Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 9: Tokio Marine Holdings, Inc.: M&A Average Deal Size - Value (US$m)
Table 10: Tokio Marine Holdings, Inc.: Targets and Partners
Table 11: Tokio Marine Holdings, Inc.: Top Deals 2014 - 2018YTD*
Table 12: Tokio Marine Holdings, Inc.: Legal Advisor Ranking by Value (US$m)
Table 13: Tokio Marine Holdings, Inc.: M&A Volume and Value Trend (2014 - YTD*2018)
Table 14: Tokio Marine Holdings, Inc.: M&A Activity by Geography (2014 - YTD*2018)
Table 15: Tokio Marine Holdings, Inc.: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Table 16: Tokio Marine Holdings, Inc.: Corporate Venturing by Geography (2014 - YTD*2018)
Table 17: Tokio Marine Holdings, Inc.: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 18: Tokio Marine Holdings, Inc.: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 19: Tokio Marine Holdings, Inc.: News and Events Summary
Table 20: Tokio Marine Holdings, Inc.: Business Expansion
Table 21: Tokio Marine Holdings, Inc.: Contracts
Table 22: Tokio Marine Holdings, Inc.: Corporate Governance
Table 23: Tokio Marine Holdings, Inc.: Financial Deals
Table 24: Tokio Marine Holdings, Inc.: Financial Performance
Table 25: Tokio Marine Holdings, Inc.: Regulatory and Legal Events
Table 26: Tokio Marine Holdings, Inc.: Strategy and Operations

List of Figures
Figure 1: Tokio Marine Holdings, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Tokio Marine Holdings, Inc.: M&A Activity by Geography (TTM*)
Figure 3: Tokio Marine Holdings, Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: Tokio Marine Holdings, Inc.: M&A Average Deal Size - Value (US$m)
Figure 5: Tokio Marine Holdings, Inc.: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 6: Tokio Marine Holdings, Inc.: M&A Activity by Geography (2014 - YTD*2018)
Figure 7: Tokio Marine Holdings, Inc.: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Figure 8: Tokio Marine Holdings, Inc.: Corporate Venturing by Geography (2014 - YTD*2018)
Figure 9: Tokio Marine Holdings, Inc.: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 10: Tokio Marine Holdings, Inc.: Partnership Trend by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[Tokio Marine Holdings, Inc.:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • iCAD Inc (ICAD)-医療機器分野:企業M&A・提携分析
    Summary iCAD Inc (iCAD) is a medical device company. It develops and markets computer aided detection (CAD) solutions and workflow solutions for mammography (film-based, digital radiography (DR) and computed radiography (CR), Magnetic Resonance Imaging (MRI), and Computed Tomography (CT). iCAD produ …
  • MDNA Life Sciences Inc-医療機器分野:企業M&A・提携分析
    Summary MDNA Life Sciences Inc (MDNA) is a molecular diagnostics company that develops molecular tests based on the mitochondrial genome. The company’s prostate core mitomic test (PCMT) based on the science of mitochondrial DNA (mtDNA) is a tissue-based prostate cancer diagnostics for prostate and o …
  • Greencore Group Plc:戦略・SWOT・企業財務分析
    Greencore Group Plc - Strategy, SWOT and Corporate Finance Report Summary Greencore Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • OraSure Technologies Inc (OSUR):医療機器:M&Aディール及び事業提携情報
    Summary OraSure Technologies Inc (OraSure) is a manufacturer and distributor of oral fluid specimen collection devices, diagnostic products and other medical devices. Its product portfolio encompasses infectious disease tests for the detection of antibodies for the HIV and Hepatitis C virus; Ebola v …
  • Industrias Penoles SAB de CV:企業の戦略・SWOT・財務情報
    Industrias Penoles SAB de CV - Strategy, SWOT and Corporate Finance Report Summary Industrias Penoles SAB de CV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Akari Therapeutics Plc (AKTX):企業の財務・戦略的SWOT分析
    Summary Akari Therapeutics Plc (Akari), formerly Celsus Therapeutics Plc is a biopharmaceutical company that develops treatments for rare and orphan autoimmune and inflammatory diseases. The company offers coversin drugs that act on complement component-C5 that helps in preventing the release of C5a …
  • Taconic Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Taconic Biosciences Inc (Taconic), formerly Taconic Farms Inc is a research model provider that offers animal health models and laboratory services. The company’s products include taconic transgenic mouse models, emerging models, cryopreserved models, traditional models, diet induced obese, …
  • Williams-Sonoma, Inc.:企業の戦略・SWOT・財務情報
    Williams-Sonoma, Inc. - Strategy, SWOT and Corporate Finance Report Summary Williams-Sonoma, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Best Western International Inc:企業の戦略・SWOT・財務情報
    Best Western International Inc - Strategy, SWOT and Corporate Finance Report Summary Best Western International Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • NETGEAR Inc. (NTGR):企業の財務・戦略的SWOT分析
    NETGEAR Inc. (NTGR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Aspect Imaging Inc:医療機器:M&Aディール及び事業提携情報
    Summary Aspect Imaging Inc (Aspect Imaging) is a medical device company that develops and manufactures magnetic resonance imaging systems. The company’s products comprise wristview medical systems, preclinical, process control, oil and gas analyzers, NMR, materials MRI and software. It offers precli …
  • Noramco Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Noramco Inc (Noramco), a subsidiary of Johnson & Johnson is a manufacturer and distributor of bulk active ingredients. The company's products comprise amphetamine L aspartate, amphetamine sulfate, dextroamphetamine saccharate, dextroamphetamine sulfate, buprenorphine base, buprenorphine HCL, …
  • PGE Polska Grupa Energetyczna SA (PGE):企業の財務・戦略的SWOT分析
    PGE Polska Grupa Energetyczna SA (PGE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Atlas Copco AB (ATCO A):石油・ガス:M&Aディール及び事業提携情報
    Summary Atlas Copco AB (Atlas Copco) is a provider of industrial productivity solutions. It develops and manufactures vacuum solutions, air treatment systems, compressors, assembly systems, construction and mining equipment, and power tools. The company’s products include vacuum solutions and air tr …
  • Foraco International SA (FAR):企業の財務・戦略的SWOT分析
    Summary Foraco International SA (Foraco) is a provider of drilling solutions for mining, energy, water and infrastructure projects. The company's drilling solutions include hydrogeological drilling, deep directional drilling, metallurgical sampling and large diameter drilling. It provides geological …
  • EnCana Corporation (ECA):石油・ガス:M&Aディール及び事業提携情報
    Summary EnCana Corp (EnCana) is an oil and gas producer. The company explores, develops, produces and markets natural gas, oil and natural gas liquids (NGLs). Its major resource plays include Montney, Duvernay, Wheatland Oil play, Deep Panuke, Horn River and other emerging plays in Canada. In the US …
  • KELAG-Karntner Elektrizitats-Aktiengesellschaft:企業の戦略的SWOT分析
    KELAG-Karntner Elektrizitats-Aktiengesellschaft - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competito …
  • PIQUR Therapeutics AG:製薬・医療:M&Aディール及び事業提携情報
    Summary PIQUR Therapeutics AG (PIQUR) is a developer of anti-cancer drugs. The company develops innovative small molecule therapeutics based on lipid kinase (PI3K) and mTOR inhibitior for the treatment of cancer and inflammatory diseases. Its pipeline products comprise PQR-309, PQR-620, PQR-530, PQR …
  • Orange SA (ORA):企業の財務・戦略的SWOT分析
    Orange SA (ORA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Atlas Copco AB:企業の戦略・SWOT・財務情報
    Atlas Copco AB - Strategy, SWOT and Corporate Finance Report Summary Atlas Copco AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆